NUTEX HEALTH INC.: current assets
Current assets for NUTEX HEALTH INC. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All NUTEX HEALTH INC. financial histories
What this measure means
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
Exact concept: us-gaap:AssetsCurrent. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2010-12-31 to 2025-12-31. The SEC response was captured on 2026-09-20.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| At date | 2025-12-31 | 538,811,000 | USD | 2026-03-05 | 10-K · 0001628280-26-015168 |
| At date | 2024-12-31 | 292,479,000 | USD | 2026-03-05 | 10-K · 0001628280-26-015168 |
| At date | 2023-12-31 | 90,848,403 | USD | 2025-11-18 | 10-K/A · 0001628280-25-052895 |
| At date | 2022-12-31 | 97,973,924 | USD | 2024-03-29 | 10-K · 0001558370-24-004287 |
| At date | 2021-12-31 | 154,015,179 | USD | 2023-03-03 | 10-K · 0001558370-23-002713 |
| At date | 2020-12-31 | 157,056 | USD | 2022-03-31 | 10-K · 0001607062-22-000229 |
| At date | 2019-12-31 | 1,243,352 | USD | 2021-04-05 | 10-K · 0001607062-21-000074 |
| At date | 2018-12-31 | 305,417 | USD | 2020-05-14 | 10-K · 0001607062-20-000125 |
| At date | 2017-12-31 | 55,080 | USD | 2019-04-17 | 10-K/A · 0001607062-19-000163 |
| At date | 2016-12-31 | 507,932 | USD | 2018-04-17 | 10-K · 0001607062-18-000127 |
| At date | 2015-12-31 | 7,634,620 | USD | 2017-04-17 | 10-K · 0001211524-17-000046 |
| At date | 2014-12-31 | 276,398 | USD | 2016-04-14 | 10-K · 0001211524-16-000203 |
| At date | 2013-12-31 | 1,050,746 | USD | 2015-04-15 | 10-K · 0001211524-15-000040 |
| At date | 2012-12-31 | 716,829 | USD | 2014-04-01 | 10-K · 0001211524-14-000027 |
| At date | 2011-12-31 | 1,759,089 | USD | 2013-06-20 | 10-K · 0001211524-13-000183 |
| At date | 2010-12-31 | 2,218,175 | USD | 2012-03-30 | 10-K · 0001211524-12-000050 |
Related financial histories
- NUTEX HEALTH INC.: total assets
- NUTEX HEALTH INC.: total liabilities
- NUTEX HEALTH INC.: stockholders equity
- NUTEX HEALTH INC.: cash and cash equivalents
- NUTEX HEALTH INC.: net income or loss
- NUTEX HEALTH INC.: operating cash flow
- NUTEX HEALTH INC.: capital expenditure payments
- NUTEX HEALTH INC.: revenue
- NUTEX HEALTH INC.: financing cash flow
- NUTEX HEALTH INC.: investing cash flow
- NUTEX HEALTH INC.: retained earnings or deficit
- NUTEX HEALTH INC.: basic weighted-average shares
- NUTEX HEALTH INC.: diluted weighted-average shares
- NUTEX HEALTH INC.: basic earnings per share
- NUTEX HEALTH INC.: diluted earnings per share
- NUTEX HEALTH INC.: income tax expense or benefit
- NUTEX HEALTH INC.: net property, plant and equipment
- NUTEX HEALTH INC.: share-based compensation expense
- NUTEX HEALTH INC.: operating income or loss
- NUTEX HEALTH INC.: interest expense
- NUTEX HEALTH INC.: current liabilities
- NUTEX HEALTH INC.: current accounts payable
- NUTEX HEALTH INC.: goodwill carrying amount
- NUTEX HEALTH INC.: net finite-lived intangible assets
- NUTEX HEALTH INC.: net current accounts receivable
- NUTEX HEALTH INC.: common-stock repurchase payments
- NUTEX HEALTH INC.: operating expenses
- NUTEX HEALTH INC.: net inventory
- NUTEX HEALTH INC.: gross profit
- NUTEX HEALTH INC.: cost of revenue
- NUTEX HEALTH INC.: research and development expense
Inspect the source
- Entity
- NUTEX HEALTH INC. / CIK 0001479681
- Captured
- 2026-09-20T09:08:51.281Z
- SEC response SHA-256
1e4c4278b3e624c66aafe376ea707c33deb0bbd1075a4c39e2ccf48ef8d47252
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001479681.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))